3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Recruiting
3
Withdrawn
1
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Ovarian Neoplasms
19
Small Cell Lung Carcinoma
9
Carcinoma, Ovarian Epithelial
8
Fallopian Tube Neoplasms
7
Recurrence
6
Brain Neoplasms
5
Neuroblastoma
4
Neoplasms
4
Lung Neoplasms
4
Medulloblastoma
3
Glioma
3
Central Nervous System Neoplasms
3
Uterine Cervical Neoplasms
2
Rhabdoid Tumor
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Familial ependymoma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Astrocytoma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Interventions
Melphalan
6
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Thiotepa
2
Etoposide
2
Busulfan
2
sargramostim
1
Vincristine
1
Topotecan
1
Temozolomide
1
Stem Cell Transplantation
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Peripheral Blood Stem Cell Transplantation
1
Mesna
1
Ifosfamide
1
Carboplatin
1
Bone Marrow Transplantation
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Retinoblastoma
×
Topotecan
×
Clear all
NCT04455139
2023-10-03
EuRbG2018
University of Lausanne Hospitals
Phase 2
Terminated
2 enrolled